268 related articles for article (PubMed ID: 29844125)
21. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication.
Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C
Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238
[TBL] [Abstract][Full Text] [Related]
22. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.
Iwasaki S; Iwasaki W; Takahashi M; Sakamoto A; Watanabe C; Shichino Y; Floor SN; Fujiwara K; Mito M; Dodo K; Sodeoka M; Imataka H; Honma T; Fukuzawa K; Ito T; Ingolia NT
Mol Cell; 2019 Feb; 73(4):738-748.e9. PubMed ID: 30595437
[TBL] [Abstract][Full Text] [Related]
23. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A.
Yang HS; Cho MH; Zakowicz H; Hegamyer G; Sonenberg N; Colburn NH
Mol Cell Biol; 2004 May; 24(9):3894-906. PubMed ID: 15082783
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
Bordeleau ME; Matthews J; Wojnar JM; Lindqvist L; Novac O; Jankowsky E; Sonenberg N; Northcote P; Teesdale-Spittle P; Pelletier J
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10460-5. PubMed ID: 16030146
[TBL] [Abstract][Full Text] [Related]
25. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis of translational efficiency reveals distinct but overlapping functions of yeast DEAD-box RNA helicases Ded1 and eIF4A.
Sen ND; Zhou F; Ingolia NT; Hinnebusch AG
Genome Res; 2015 Aug; 25(8):1196-205. PubMed ID: 26122911
[TBL] [Abstract][Full Text] [Related]
27. Targeting RNA helicases in cancer: The translation trap.
Heerma van Voss MR; van Diest PJ; Raman V
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):510-520. PubMed ID: 28965870
[TBL] [Abstract][Full Text] [Related]
28. Programmed cell death 4 mechanism of action: The model to be updated?
Vikhreva PN; Kalinichenko SV; Korobko IV
Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
[TBL] [Abstract][Full Text] [Related]
29. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
[TBL] [Abstract][Full Text] [Related]
30. Roles of helicases in translation initiation: a mechanistic view.
Marintchev A
Biochim Biophys Acta; 2013 Aug; 1829(8):799-809. PubMed ID: 23337854
[TBL] [Abstract][Full Text] [Related]
31. A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.
Tsai BP; Jimenez J; Lim S; Fitzgerald KD; Zhang M; Chuah CT; Axelrod H; Wilson L; Ong ST; Semler BL; Waterman ML
Open Biol; 2014 Nov; 4(11):140180. PubMed ID: 25392452
[TBL] [Abstract][Full Text] [Related]
32. Functional 5' UTR mRNA structures in eukaryotic translation regulation and how to find them.
Leppek K; Das R; Barna M
Nat Rev Mol Cell Biol; 2018 Mar; 19(3):158-174. PubMed ID: 29165424
[TBL] [Abstract][Full Text] [Related]
33. Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity.
Low WK; Dang Y; Bhat S; Romo D; Liu JO
Chem Biol; 2007 Jun; 14(6):715-27. PubMed ID: 17584618
[TBL] [Abstract][Full Text] [Related]
34. Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.
Thompson PA; Eam B; Young NP; Fish S; Chen J; Barrera M; Howard H; Sung E; Parra A; Staunton J; Chiang GG; Gerson-Gurwitz A; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Xiang A; Nilewski C; Packard GK; Michels T; Tran C; Sprengeler PA; Ernst JT; Reich SH; Webster KR
Mol Cancer Ther; 2021 Jan; 20(1):26-36. PubMed ID: 33037136
[TBL] [Abstract][Full Text] [Related]
35. A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer.
Cencic R; Im YK; Naineni SK; Moustafa-Kamal M; Jovanovic P; Sabourin V; Annis MG; Robert F; Schmeing TM; Koromilas A; Paquet M; Teodoro JG; Huang S; Siegel PM; Topisirovic I; Ursini-Siegel J; Pelletier J
Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2318093121. PubMed ID: 38232291
[TBL] [Abstract][Full Text] [Related]
36. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.
Piserà A; Campo A; Campo S
J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141
[TBL] [Abstract][Full Text] [Related]
37. A cross-kingdom internal ribosome entry site reveals a simplified mode of internal ribosome entry.
Terenin IM; Dmitriev SE; Andreev DE; Royall E; Belsham GJ; Roberts LO; Shatsky IN
Mol Cell Biol; 2005 Sep; 25(17):7879-88. PubMed ID: 16107731
[TBL] [Abstract][Full Text] [Related]
38. Targeting the eIF4A RNA helicase as an anti-neoplastic approach.
Chu J; Pelletier J
Biochim Biophys Acta; 2015 Jul; 1849(7):781-91. PubMed ID: 25234619
[TBL] [Abstract][Full Text] [Related]
39. The RNA Helicase eIF4A Is Required for Sapovirus Translation.
Hosmillo M; Sweeney TR; Chaudhry Y; Leen E; Curry S; Goodfellow I; Cho KO
J Virol; 2016 May; 90(10):5200-5204. PubMed ID: 26937032
[TBL] [Abstract][Full Text] [Related]
40. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
Waldron JA; Tack DC; Ritchey LE; Gillen SL; Wilczynska A; Turro E; Bevilacqua PC; Assmann SM; Bushell M; Le Quesne J
Genome Biol; 2019 Dec; 20(1):300. PubMed ID: 31888698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]